Toxoplasma gondii dysregulates IFN-γ-inducible gene expression in human fibroblasts: Insights from a genome-wide transcriptional profiling

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5154-5165

  Kim, Seon Kyeong ^a   Fouts, Ashley E ^a   Boothroyd, John C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; STAT1 PROTEIN;

ANIMAL MODEL; ARTICLE; CELL NUCLEUS; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERFERON GAMMA INDUCIBLE GENE; MICROARRAY ANALYSIS; NEOSPORA CANINUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TOXOPLASMA GONDII; TOXOPLASMOSIS; UNINDEXED SEQUENCE; UPREGULATION;

EID: 34247140278     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5154     Document Type: Article

References (62)

1. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
2. Suzuki, Y., F. K. Conley, and J. S. Remington. 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143: 2045-2050.
3. Aline, F., D. Bout, and I. Dimier-Poisson. 2002. Dendritic cells as effector cells: γ interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication. Infect. Immun. 70: 2368-2374.
4. Ceravolo, I. P., A. C. Chaves, C. A. Bonjardim, D. Sibley, A. J. Romanha, and R. T. Gazzinelli. 1999. Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with γ interferon: requirement of a functional JAK/STAT pathway. Infect. Immun. 67: 2233-2240.
5. Halonen, S. K., G. A. Taylor, and L. M. Weiss. 2001. γ Interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect. Immun. 69: 5573-5576.
6. Pfefferkorn, E. R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tiyptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
7. Bohne, W., J. Heesemann, and U. Gross. 1993. Induction of bradyzoite-specific Toxoplasma gondii antigens in γ interferon-treated mouse macrophages. Infect. Immun. 61: 1141-1145.
8. Jones, T. C., K. A. Bienz, and P. Erb. 1986. In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of γ interferon. Infect. Immun. 51: 147-156.
9. Robben, P. M., D. G. Mordue, S. M. Truscott, K. Takeda, S. Akira, and L. D. Sibley. 2004. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 172: 3686-3694.
10. Kim, S. K., and J. C. Boothroyd. 2005. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J. Immunol. 174: 8038-8048.
11. Lang, C., M. Algner, N. Beinert, U. Gross, and G. G. Luder. 2006. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-γ-induced major histocompatibility complex class 11 gene expression. Microbes. Infect. 8: 1994-2005.
12. Luder, C. G., W. Walter, B. Beuerle, M. J. Maeurer, and U. Gross. 2001. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1α. Eur. J. Immunol. 31: 1475-1484.
13. Zimmermann, S., P. J. Murray, K. Heeg, and A. H. Dalpke. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-γ signaling. J. Immunol. 176: 1840-1847.
14. Dubey, J. P. 1997. Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradyzoites of different strains of Toxoplasma gondii. J. Eukaryotic Microbiol. 44: 592-602.
15. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
16. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
17. Varinou, L., K. Ramsauer, M. Karaghiosoff, T. Kolbe, K. Pfeffer, M. Muller, and T. Decker. 2003. Phosphorylation of the Stall transactivation domain is required for full-fledged IFN-γ-dependent innate immunity. Immunity 19: 793-802.
18. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylalion. Cell 82: 241-250.
19. Dubey, J. P. 1997. Distribution of tissue cysts in organs of rats fed Toxoplasma gondii oocysts. J. Parasitol. 83: 755-757.
20. Dubey, J. P. 1997. Tissue cyst tropism in Toxoplasma gondii: a comparison of tissue cyst formation in organs of cats, and rodents fed oocysts. Parasitology 115(Pt. 1): 15-20.
21. Buckley, C. D., D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasls regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22: 199-204.
22. Boyle, J. P., B. Rajasekar, J. P. Saeij, J. W. Ajioka, M. Berriman, I. Paulsen, D. S. Roos, L. D. Sibley, M. W. White, and J. C. Boothroyd. 2006. Just one cross appears capable of dramatically altering the population biology of a eukaryotic pathogen like Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 103: 10514-10519.
23. Speer, C. A., J. P. Dubey, M. M. McAllister, and J. A. Blixt 1999. Comparative ultrastructure of tachyzoites, bradyzoites, and tissue cysts of Neospora caninum and Toxoplasma gondii. Int. J. Parasitol. 29: 1509-1519.
24. Dubey, J. P., and D. S. Lindsay. 1993. Neosporosis. Parasitol. Today 9: 452-454.
25. Saeij, J. P., J. P. Boyle, and J. C. Boothroyd. 2005. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 21: 476-481.
26. Boothroyd, J. C., and M. E. Grigg. 2002. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr. Opin. Microbiol. 5: 438-442.
27. Baszler, T. V., M. T. Long, T. F. McElwain, and B. A. Mathison. 1999. Interferon-γ and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int. J. Parasitol. 29: 1635-1646.
28. Walker, W., C. W. Roberts, D. J. Ferguson, H. Jebbari, and J. Alexander. 1997. Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and γ interferon production. Infect. Immun. 65: 1119-1121.
29. Mercier, C., S. Lefebvre-Van Hende, G. E. Garber, L. Lecordier, A. Capron, and M. F. Cesbron-Delauw. 1996. Common cis-acting elements critical for the expression of several genes of Toxoplasma gondii. Mol. Microbiol. 21: 421-428.
30. Eisen, M. B., and P. O. Brown. 1999. DNA arrays for analysis of gene expression. Methods Enzymol. 303: 179-205.
31. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
32. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
33. Rivieccio, M. A., G. R. John, X. Song, H. S. Suh, Y. Zhao, S. C. Lee, and C. F. Brosnan. 2005. The cytokine IL-1β activates IFN response factor 3 in human fetal astrocytes in culture. J. Immunol. 174: 3719-3726.
34. Zhu, H., and C. Liu. 2003. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J. Virol. 77: 5493-5498.
35. Chernajovsky, Y., and T. R. Reid. 1990. Regulation of the human interferon-inducible 6-16 promoter in tumor necrosis factor-sensitive and resistant mouse cells: role of cAMP as a mediator of signal transduction. J. Interferon Res. 10: 627-636.
36. O'Neill, L. A., and C. Greene. 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukocyte Biol. 63: 650-657.
37. Tian, B., D. E. Nowak, M. Jamaluddin, S. Wang, and A. R. Brasier. 2005. Identification of direct genomic targets downstream of the nuclear factor-κB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280: 17435-17448.
38. Lockwood, C. J., P. Malta, G. Krikun, L. A. Koopman, R. Masch, P. Toti, F. Arcuri, S. T. Huang, E. F. Funai, and F. Schatz. 2006. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-α and interleukin-1β in first trimester human decidual cells: implications for preeclampsia. Am. J. Pathol. 168: 445-452.
39. Wei, L., M. R. Sandbulte, P. G. Thomas, R. J. Webby, R. Homayouni, and L. M. Pfeffer. 2006. NFκB negatively regulates interferon-induced gene expression and anti-influenza activity. J. Biol. Chem. 281: 11678-11684.
40. O'Donnell, S. M., G. H. Holm, J. M. Pierce, B. Tian, M. J. Watson, R. S. Chari, D. W. Ballard, A. R. Brasier, and T. S. Dermody. 2006. Identification of an NF-κB-dependent gene network in cells infected by mammalian reovirus. J. Virol. 80: 1077-1086.
41. Collazo, C. M., G. S. Yap, S. Hieny, P. Caspar, C. G. Feng, G. A. Taylor, and A. Sher. 2002. The function of γ interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments. Infect. Immun. 70: 6933-6939.
42. Gil, M. P., E. Bohn, A. K. O'Guin, C. V. Ramana, B. Levine, G. R. Stark, H. W. Virgin, and R. D. Schreiber. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl Acad. Sci. USA 98: 6680-6685.
43. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
44. Silva, N. M., C. V. Rodrigues, M. M. Santoro, L. F. Reis, J. I. Alvarez-Leite, and R. T. Gazzinelli. 2002. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous γ interferon and requirement of interferon regulatory factor 1. Infect. Immun. 70: 859-868.
45. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608.
46. Shuai, K., and B. Liu. 2005. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5: 593-605.
47. Radaeva, S., B. Jaruga, W. H. Kim, T. Heller, T. J. Liang, and B. Gao. 2004. Interferon-γ inhibits interferon-α signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C. Biochem. J. 379: 199-208.
48. Reich, N. C., and L. Liu. 2006. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6: 602-612.
49. Schindler, C., K. Shuai, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813.
50. Vinkermeier, U. 2004. Getting the message across STAT: design principles of a molecular signaling circuit. J. Cell Biol. 167: 197-201.
51. Ramana, C. V., M. Chatterjee-Kishore, H. Nguyen, and G. R. Stark. 2000. Complex roles of Stat1 in regulating gene expression. Oncogene 19: 2619-2627.
52. Andrejeva, J., D. F. Young, S. Goodbourn, and R. E. Randall. 2002. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of α/β and γ interferons. J. Virol. 76: 2159-2167.
53. Siewert, E., W. Muller-Esterl, R. Starr, P. C. Heinrich, and F. Schaper. 1999. Different protein turnover of interleukin-6-type cytokine signalling components. Eur. J. Biochem. 265: 251-257.
54. Xuan, Y. T., Y. Guo, Y. Zhu, O. L. Wang, G. Rokosh, R. O. Messing, and R. Bolli. 2005. Role of the protein kinase C-ε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112: 1971-1978.
55. Rozenfeld, C., R. Martinez, S. Seabra, C. Sant'anna, J. G. Goncalves, M. Bozza, V. Moura-Neto, and W. De Souza. 2005. Toxoplasma gondii prevents neuron degeneration by interferon-γ-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-β1 production by infected microglia. Am. J. Pathol. 167: 1021-1031.
56. Takaki, H., Y. Minoda, K. Koga, G. Takaesu, A. Yoshimura, and T. Kobayashi. 2006. TGF-β1 suppresses IFN-γ-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Genes Cells 11: 871-882.
57. Dunn, J. D., B. Butcher, E. Denkers, and J. C. Boothroyd. 2006. Alterations in host-cell biology due to Toxoplasma gondii. In Toxoplasma gondii: The Model Apicomplexan-Perspectives and Methods. K. Kim and L. Weiss, eds. Elsevier, New York, pp. 317-340.
58. Gilbert, L. A., S. Ravindran, J. M. Turetzky, J. C. Boothroyd, and P. J. Bradley. 2007. Toxoplasma gondii targets a protein phosphatase 2C to the nucleus of infected host cells. Eukaryot. Cell 6: 73-83.
59. Saeij, J. P. J., S. Coller, J. P. Boyle, M. E. Jerome, M. W. White, and J. C. Boothroyd. 2007. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327.
60. Long, M. T., T. V. Baszler, and B. A. Mathison. 1998. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J. Parasitol. 84: 316-320.
61. Saeij, J. P., J. P. Boyle, M. E. Grigg, G. Arrizabalaga, and J. C. Boothroyd. 2005. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect. Immun. 73: 695-702.
62. Rettigner, C., T. Leclipteux, F. De Meerschman, C. Focant, and B. Losson. 2004. Survival, immune responses and tissue cyst production in outbred (Swiss white) and inbred (CBA/Ca) strains of mice experimentally infected with Neospora caninum tachyzoites. Vet. Res. 35: 225-232.